SDH of HPV Vaccine Completion

Study Overview
=================
Brief Summary
-----------------
The purpose of this research study is to find out which factors influence parents' ability to complete the human papillomavirus (HPV) vaccine series for their child. The information learned from this study may help the investigators develop programs to improve HPV vaccine completion rates among adolescents and reduce barriers to receiving the second shot of the vaccine series.

Official Title
-----------------
Social Determinants of HPV Vaccine Completion Among Adolescents

Conditions
-----------------
Human Papilloma Virus

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: For adolescents, participants need to be between the ages 11 to 14 years. Received 1 dose of the HPV vaccine series between January 2017 and December 2017. For parents, there is no age limit required. Parents as defined as the adolescent's biological mother or father, step-parents, or legal guardian. Parents or legal guardians who self-identified as the primary caregiver of the adolescent child and most likely to make medical decisions for the adolescent. Exclusion Criteria: Parents with cognitive impairment. Adolescents with cognitive impairment. Adolescents emancipated from their parents or legal guardian Pregnant adolescent girls.
Sexes Eligible for Study
-----------------
All

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Adolescents ages 11 to 14 years<br>Adolescents ages 11 to 14 years who have received 1 dose of the HPV vaccine series between January 2017 and December 2017 | |
| Parent of adolescents<br>Parents as defined as the adolescent's biological mother or father, step-parents, or legal guardian, and who self-identified as the primary caregiver of the adolescent child and most likely to make medical decisions for the adolescent. | |
| Cohort of Adolescents From Electronic Health Record (EHR)<br>A cohort of adolescents ages 11 to 14 who received 1 dose of the HPV vaccine from January 2017 to December 2017 within the university's health system network. The cohort was followed from January 2018 to February 2019 to assess vaccine completion within a 14-month period. | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Overall HPV Vaccine Completion Rates | Adolescents who completed the required HPV vaccine doses (e.g. two or three doses based on the CDC's vaccine administration guidelines for adolescents' ages 11 to 14 years) during the January 2017 to February 2019 observation period. | up to 14 months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| HPV Vaccine Completion Within 14-Months | Adolescents who received the required number of doses for vaccine completion, defined as the receipt of two or three doses based on the CDC's guidelines for adolescents' ages 11 to 14 years, within 14-months from their first vaccine dose. | within 14 months | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
HPV, adolescents, HPV Vaccine, social determinants